Return
Role of Hypoxia-Inducible Factor–1α in Regulating Muscle Degeneration After Rotator Cuff Tears
H
A
M
A
Y
H
B
X
DOI:10.1177/03635465261469689.png)
Abstract
En 中文
<jats:sec>
<jats:title>Background:</jats:title>
<jats:p>Secondary muscle degeneration after a rotator cuff tear (RCT) critically affects clinical outcomes. Vascular compromise after a tendon injury creates a complex microenvironment that may be associated with the degeneration of rotator cuff muscle. The role of hypoxia-inducible factor–1α (HIF-1α), a master regulator of cellular stress responses to hypoxia, in modulating muscle abnormalities after an RCT remains undefined.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Purpose:</jats:title>
<jats:p>To define the role of HIF-1α in stem cell differentiation and muscle degeneration after an RCT in a murine model.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Study Design:</jats:title>
<jats:p>Controlled laboratory study.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Methods:</jats:title>
<jats:p>A supraspinatus tendon transection and suprascapular nerve transection (TTDN) model was established in C57BL/6J, platelet-derived growth factor receptor α (PDGFRα)–green fluorescent protein (GFP) reporter, and inducible cell-specific HIF-1α knockout mice. Vascularity and HIF-1α colocalization with fibroadipogenic progenitor (FAP) cells and satellite cells were analyzed. Fibrosis, fatty infiltration, and myofiber cross-sectional area were assessed. In vitro, HIF-1α was modulated in isolated FAP cells via CRISPR-Cas9 or prolyl hydroxylase domain inhibitors to evaluate FAP cell differentiation.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Results:</jats:title>
<jats:p>
TTDN induced significant capillary density reduction (CD31
<jats:sup>+</jats:sup>
) at 1, 2, and 6 weeks after an injury. Global HIF-1α expression decreased after TTDN compared to the sham side (1 week: 0.78 ± 0.22 vs 1.40 ± 0.42, respectively [
<jats:italic toggle="yes">P</jats:italic>
= .019]; 2 weeks: 0.74 ± 0.51 vs 1.70 ± 0.48, respectively [
<jats:italic toggle="yes">P</jats:italic>
= .015]). The percentage of PDGFRα
<jats:sup>+</jats:sup>
FAP cells increased at 6 weeks after TTDN compared to the sham side (15.69% ± 1.90% vs 12.76% ± 0.78%, respectively;
<jats:italic toggle="yes">P</jats:italic>
= .013). The percentage of HIF-1α
<jats:sup>+</jats:sup>
FAP cells relative to total PDGFRα
<jats:sup>+</jats:sup>
cells significantly decreased in the late stage (6 weeks) of an RCT compared to the sham side (2.78% ± 0.90% vs 7.38% ± 2.29%, respectively;
<jats:italic toggle="yes">P</jats:italic>
= .003). Knocking out HIF-1α in FAP cells in vivo resulted in increased fibrosis (Cre
<jats:sup>+</jats:sup>
: 4.43% ± 2.16% vs Cre
<jats:sup>–</jats:sup>
: 1.72% ± 0.39%;
<jats:italic toggle="yes">P</jats:italic>
= .047), decreased fatty infiltration (Cre
<jats:sup>+</jats:sup>
: 0.62% ± 0.42% vs Cre
<jats:sup>–</jats:sup>
: 1.55% ± 0.45%;
<jats:italic toggle="yes">P</jats:italic>
= .016), and reduced cross-sectional area (Cre
<jats:sup>+</jats:sup>
: 664.71 ± 354.45 vs Cre
<jats:sup>–</jats:sup>
: 1195.81 ± 338.66;
<jats:italic toggle="yes">P</jats:italic>
= .041). Neither satellite cell–specific nor myocyte-specific HIF-1α deletion resulted in significant phenotypic changes. The downregulation of HIF-1α led to a decrease in uncoupling protein 1 expression and an increase in α–smooth muscle actin expression in FAP cells.
</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Conclusion:</jats:title>
<jats:p>Although vascularity was reduced after TTDN, pronounced global tissue hypoxia was not directly evidenced. Decreased global HIF-1α expression may reflect denervation-induced reductions in metabolic demand. HIF-1α emerges as a key player in FAP cell differentiation within the injury microenvironment, promoting brown adipose tissue differentiation and inhibiting fibrogenesis.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Clinical Relevance:</jats:title>
<jats:p>Targeting HIF-1α in FAP cells offers a novel therapeutic strategy to mitigate secondary muscle atrophy and fibrosis after an RCT.</jats:p>
</jats:sec>
Journal
IF:
4.5
Papers:
9.4K
Citations:
4.0W
